In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users]-Forecast To 2017

世界の体外診断(IVD)市場

◆タイトル:In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users]-Forecast To 2017
◆商品コード:PH 2087
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年8月
◆ページ数:418
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate licence(社内共有可) USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界の体外診断(IVD)市場"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の機会と課題、サプライチェーン分析、市場の動態、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. The global in vitro disgnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.

In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

Scope of the Report

This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels.

Global IVD Market, by Technique:

Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation
Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry)

Global IVD Market, by Product Type:

Reagents
Instruments
Services
Data Management System Software/Hardware

Global IVD Market, by Application:

Diabetes
Infectious Diseases
Oncology
Cardiology
HIV/AIDS
Autoimmune Diseases
Drug Testing
Nephrology
Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications)

Global IVD Market, by End-Users:

Hospitals
Laboratories
Patient Self-testing
POCT (Point-of-Care Testing)
Academics (academic medical centers/research laboratories, university laboratories, etc.)
Others (blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical centers)

In Vitro Diagnostic Market, by Geography:

The Americas
U.S.
Canada
Mexico
Chile
Rest of America
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Japan
BRIC
Brazil
Russia
India
China
Rest of the World

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 23)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. – 30)

3 Market Overview (Page No. – 33)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers & Restraint
3.3.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Market
3.3.1.2 Rapidly Aging Population
3.3.1.3 Rise In Point-Of-Care (POC) Testing
3.3.1.4 Personalized Medicine To Propel Growth
3.3.1.5 Lack Of Budget To Restrict Growth
3.3.2 Opportunities
3.3.2.1 Extending Reach Of Molecular Diagnostics
3.3.2.2 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
3.3.3 Challenge
3.3.3.1 Stringent Regulatory Framework Acts As A Major Challenge
3.4 Winning Imperatives
3.4.1 Non-Proprietary System With Enhanced Functionalities
3.5 Burning Issues
3.5.1 Laboratory Automation For Increased Efficiency And Accurate Diagnosis
3.6 Market Share Analysis
3.7 Supply Chain Analysis
3.8 Pestel Analysis
3.8.1 Political
3.8.2 Economic
3.8.3 Socio-Cultural
3.8.4 Technological
3.8.5 Environmental
3.8.6 Legal

4 By Technique (Page No. – 52)
4.1 Introduction
4.1.1 Clinical Chemistry
4.1.2 Immunochemistry/Immunoassay
4.1.3 Hematology
4.1.4 Coagulation
4.1.5 Microbiology
4.1.6 Molecular Diagnostics
4.1.7 Other Clinical Instruments

5 By Product Type (Page No. – 90)
5.1 Introduction
5.2 Instruments
5.3 Reagents
5.4 Data Management System Software/Hardware
5.5 Services

6 By Application (Page No. – 111)
6.1 Introduction
6.2 Diabetes
6.3 Infectious Diseases
6.4 Oncology/Cancer
6.5 Cardiology
6.6 Nephrology
6.7 Autoimmune Diseases
6.8 Drug Testing
6.9 HIV/Aids
6.10 Others

7 By End-User (Page No. – 158)
7.1 Introduction
7.2 Laboratory
7.3 Hospitals
7.4 Academics
7.5 Point-Of-Care Testing
7.6 Patient Self-Testing
7.7 Others

8 Geographic Analysis (Page No. – 164)
8.1 Introduction
8.2 Americas
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.2.4 Chile
8.2.5 Rest Of Americas (ROA)
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 Italy
8.3.4 Spain
8.3.5 U.K.
8.3.6 Rest Of Europe (ROE)
8.4 Japan
8.5 Bric
8.5.1 Brazil
8.5.2 Russia
8.5.3 India
8.5.4 China
8.6 Rest Of The World (ROW)

9 Competitive Landscape (Page No. – 243)
9.1 Introduction
9.2 New Product Launch
9.3 Agreements, Partnerships, Collaborations & Joint Ventures
9.4 Mergers And Acquisitions
9.5 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)* (Page No. – 282)
10.1 Abbott Laboratories, Inc.
10.2 Alere, Inc.
10.3 Arkray, Inc.
10.4 Bayer AG
10.5 Becton, Dickinson And Company
10.6 Biomerieux
10.7 Bio-Rad Laboratories, Inc.
10.8 Danaher Corporation
10.9 Diagnostica Stago Sas
10.10 Diasorin S.P.A.
10.11 Hologic, Inc.
10.12 Horiba, Ltd.
10.13 Johnson & Johnson
10.14 Novartis International Ag
10.15 Qiagen N.V.
10.16 Roche Diagnostics Limited
10.17 Siemens Healthcare
10.18 Sysmex Corporation
10.19 Thermo Fisher Scientific, Inc.
*Details On Financials, Products & Services, Developments & Strategy Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables (178 Tables)

Table 1 Global In-Vitro Diagnostic Instrument & Reagents Market Revenue, By Technique, 2012 ($Million)
Table 2 Clinical Chemistry Market, By Geography, 2010-2017 ($Million)
Table 3 The Americas: Clinical Chemistry Market, By Country, 2010-2017 ($Million)
Table 4 Europe: Clinical Chemistry Market, By Country, 2010-2017 ($Million)
Table 5 BRIC: Clinical Chemistry Market, By Country, 2010-2017 ($Million)
Table 6 Global Clinical Chemistry Market, By Instruments & Reagents, 2010-2017 ($Million)
Table 7 Immunochemistry Market, By Geography, 2010-2017 ($Million)
Table 8 The Americas: Immunochemistry Market, By Country, 2010-2017 ($Million)
Table 9 Europe: Immunochemistry Market, By Country, 2010-2017 ($Million)
Table 10 BRIC: Immunochemistry Market, By Country, 2010-2017 ($Million)
Table 11 Global Immunochemistry Market, By Instruments & Reagents, 2010-2017 ($Million)
Table 12 Hematology Market, By Geography, 2010-2017 ($Million)
Table 13 The Americas: Hematology Market, By Country, 2010-2017 ($Million)
Table 14 Europe: Hematology Market, By Country, 2010-2017 ($Million)
Table 15 BRIC: Hematology Market, By Country, 2010-2017 ($Million)
Table 16 Global Hematology Market, By Instruments & Reagents, 2010-2017 ($Million)
Table 17 Coagulation Market, By Geography, 2010-2017 ($Million)
Table 18 The Americas: Coagulation Market, By Country, 2010-2017 ($Million)
Table 19 Europe: Coagulation Market, By Country, 2010-2017 ($Million)
Table 20 BRIC: Coagulation Market, By Country, 2010-2017 ($Million)
Table 21 Global Coagulation Market, By Instruments & Reagents, 2010-2017 ($Million)
Table 22 Microbiology Market, By Geography, 2010-2017 ($Million)
Table 23 The Americas: Microbiology Market, By Country, 2010-2017 ($Million)
Table 24 Europe: Microbiology Market, By Country, 2010-2017 ($Million)
Table 25 BRIC: Microbiology Market, By Country, 2010-2017 ($Million)
Table 26 Global Microbiology Market, By Instruments & Reagents, 2010-2017 ($Million)
Table 27 Molecular Diagnostics Market, By Geography, 2010-2017 ($Million)
Table 28 The Americas: Molecular Diagnostics Market, By Country, 2010-2017 ($Million)
Table 29 Europe: Molecular Diagnostics Market, By Country, 2010-2017 ($Million)
Table 30 BRIC: Molecular Diagnostics Market, By Country, 2010-2017 ($Million)
Table 31 Global Molecular Diagnostics Market, By Instruments & Reagents, 2010-2017 ($Million)
Table 32 Other In-Vitro Diagnostic Techniques Market, By Geography, 2010-2017 ($Million)
Table 33 The Americas: Other In Vitro Diagnostic Techniques Market, By Country, 2010-2017 ($Million)
Table 34 Europe: Other In Vitro Diagnostic Techniques Market, By Country, 2010-2017 ($Million)
Table 35 BRIC: Other In Vitro Diagnostic Techniques Market, By Country, 2010-2017 ($Million)
Table 36 Global In Vitro Diagnostic Market, By Product Type, 2010-2017 ($Million)
Table 37 In Vitro Diagnostic Instruments Market, By Geography, 2010-2017 ($Million)
Table 38 The Americas: IVD Instruments Market, By Country, 2010-2017 ($Million)
Table 39 Europe: IVD Instruments Market, By Country, 2010-2017 ($Million)
Table 40 BRIC: IVD Instruments Market, By Country, 2010-2017 ($Million)
Table 41 In Vitro Diagnostic Reagents Market, By Geography, 2010-2017 ($Million)
Table 42 The Americas: IVD Reagents Market, By Country, 2010-2017 ($Million)
Table 43 Europe: IVD Reagents Market, By Country, 2010-2017 ($Million)
Table 44 BRIC: IVD Reagents Market, By Country, 2010-2017 ($Million)
Table 45 In Vitro Diagnostic Data Management System Software/Hardware Market, By Geography, 2010-2017 ($Million)
Table 46 The Americas: In Vitro Diagnostic Data Management System Software/Hardware Market, By Country, 2010-2017 ($Million)
Table 47 Europe: In Vitro Diagnostic Data Management System Software/Hardware Market, By Country, 2010-2017 ($Million)
Table 48 BRIC: In Vitro Diagnostic Data Management System Software/Hardware Market, By Country, 2010-2017 ($Million)
Table 49 In Vitro Diagnostic Services Market, By Geography, 2010-2017 ($Million)
Table 50 The Americas: In Vitro Diagnostic Services Market, By Country, 2010-2017 ($Million)
Table 51 Europe: In Vitro Diagnostic Services Market, By Country, 2010-2017 ($Million)
Table 52 BRIC: In Vitro Diagnostic Services Market, By Country, 2010-2017 ($Million)
Table 53 Global In-Vitro Diagnostics Market, By Application, 2010-2017 ($Million)
Table 54 Diabetes In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 55 Americas: Diabetes In Vitro Diagnostic Market, By Country, 2010-2017 ($Million)
Table 56 Europe: Diabetes In Vitro Diagnostic Market, By Country, 2010-2017 ($Million)
Table 57 BRIC: Diabetes In Vitro Diagnostic Market, By Country, 2010-2017 ($Million)
Table 58 Infectious Diseases In Vitro Diagnostics Market, By Geography, 2010-2017 ($Million)
Table 59 Americas: Infectious Diseases Market, By Country, 2010-2017 ($Million)
Table 60 Europe: Infectious Diseases Market, By Country, 2010-2017 ($Million)
Table 61 BRIC: Infectious Diseases Market, By Country, 2010-2017 ($Million)
Table 62 Oncology In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 63 Americas: Oncology Market, By Country, 2010-2017 ($Million)
Table 64 Europe: Oncology Market, By Country, 2010-2017 ($Million)
Table 65 BRIC: Oncology Market, By Country, 2010-2017 ($Million)
Table 66 Cardiology In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 67 Americas: Cardiology Market, By Country, 2010-2017 ($Million)
Table 68 Europe: Cardiology Market, By Country, 2010-2017 ($Million)
Table 69 BRIC: Cardiology Market, By Country, 2010-2017 ($Million)
Table 70 Nephrology In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 71 Americas: Nephrology Market, By Country, 2010-2017 ($Million)
Table 72 Europe: Nephrology Market, By Country, 2010-2017 ($Million)
Table 73 BRIC: Nephrology Market, By Country, 2010-2017 ($Million)
Table 74 Autoimmune Diseases In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 75 America: Autoimmune Diseases Market, By Country, 2010-2017 ($Million)
Table 76 Europe: Autoimmune Diseases Market, By Country, 2010-2017 ($Million)
Table 77 BRIC: Autoimmune Diseases Market, By Country, 2010-2017 ($Million)
Table 78 Drug Testing In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 79 Americas: Drug Testing Market, By Country, 2010-2017 ($Million)
Table 80 Europe: Drug Testing In Vitro Diagnostic Market, By Country, 2010-2017 ($Million)
Table 81 BRIC: Drug Testing In Vitro Diagnostic Market, By Country, 2010-2017 ($Million)
Table 82 HIV/Aids In Vitro Diagnostic Market, By Geography, 2010-2017 ($Million)
Table 83 Americas: Hiv/Aids IVD Market, By Country, 2010-2017 ($Million)
Table 84 Europe: Hiv/Aids IVD Market, By Country, 2010-2017 ($Million)
Table 85 BRIC: Hiv/Aids IVD Market, By Country, 2010-2017 ($Million)
Table 86 Other Applications Market, By Geography, 2010-2017 ($Million)
Table 87 America: Other Applications Market, By Country, 2010-2017 ($Million)
Table 88 Europe: Other Applications Market, By Country, 2010-2017 ($Million)
Table 89 BRIC: Other Applications Market, By Country, 2010-2017 ($Million)
Table 90 Global In Vitro Diagnostics Market, By End-User, 2010-2017 ($Million)
Table 91 In Vitro Diagnostics Market, By Geography, 2010-2017 ($Million)
Table 92 Americas: IVD Market, By Country, 2010-2017 ($Million)
Table 93 Americas: By Technique, 2010-2017 ($Million)
Table 94 Americas: By Application, 2010-2017 ($Million)
Table 95 Americas: By Product Type, 2010-2017 ($Million)
Table 96 U.S.: IVD Market, By Technique, 2010-2017 ($Million)
Table 97 U.S.: By Application, 2010-2017 ($Million)
Table 98 U.S.: By Product Type, 2010-2017 ($Million)
Table 99 Canada: IVD Market, By Technique, 2010-2017 ($Million)
Table 100 Canada: By Application, 2010-2017 ($Million)
Table 101 Canada: By Product Type, 2010-2017 ($Million)
Table 102 Mexico: IVD Market, By Technique, 2010-2017 ($Million)
Table 103 Mexico: By Application, 2010-2017 ($Million)
Table 104 Mexico: By Product Type, 2010-2017 ($Million)
Table 105 Chile: IVD Market, By Technique, 2010-2017 ($Million)
Table 106 Chile: By Application, 2010-2017 ($Million)
Table 107 Chile: By Product Type, 2010-2017 ($Million)
Table 108 ROA: IVD Market, By Technique, 2010-2017 ($Million)
Table 109 ROA: By Application, 2010-2017 ($Million)
Table 110 ROA: By Product Type, 2010-2017 ($Million)
Table 111 Europe: IVD Market, By Country, 2010-2017 ($Million)
Table 112 Europe: By Technique, 2010-2017 ($Million)
Table 113 Europe: By Application, 2010-2017 ($Million)
Table 114 Europe: By Product Type, 2010-2017 ($Million)
Table 115 Germany: IVD Market, By Technique, 2010-2017 ($Million)
Table 116 Germany: By Application, 2010-2017 ($Million)
Table 117 Germany: By Product Type, 2010-2017 ($Million)
Table 118 France: IVD Market, By Technique, 2010-2017 ($Million)
Table 119 France: By Application, 2010-2017 ($Million)
Table 120 France: By Product Type, 2010-2017 ($Million)
Table 121 Italy: IVD Market, By Technique, 2010-2017 ($Million)
Table 122 Italy: By Application, 2010-2017 ($Million)
Table 123 Italy: By Product Type, 2010-2017 ($Million)
Table 124 Spain: IVD Market, By Technique, 2010-2017 ($Million)
Table 125 Spain: By Application, 2010-2017 ($Million)
Table 126 Spain: By Product Type, 2010-2017 ($Million)
Table 127 U.K.: IVD Market, By Technique, 2010-2017 ($Million)
Table 128 U.K.: By Application, 2010-2017 ($Million)
Table 129 U.K.: By Product Type, 2010-2017 ($Million)
Table 130 ROE: By Technique, 2010-2017 ($Million)
Table 131 ROE: By Application, 2010-2017 ($Million)
Table 132 ROE: By Product Type, 2010-2017 ($Million)
Table 133 Japan: IVD Market, By Technique, 2010-2017 ($Million)
Table 134 Japan: By Application, 2010-2017 ($Million)
Table 135 Japan: By Product Type, 2010-2017 ($Million)
Table 136 BRIC: IVD Market, By Country, 2010-2017 ($Million)
Table 137 BRIC: By Technique, 2010-2017 ($Million)
Table 138 BRIC: By Application, 2010-2017 ($Million)
Table 139 BRIC: By Product Type, 2010-2017 ($Million)
Table 140 Brazil: IVD Market, By Technique, 2010-2017 ($Million)
Table 141 Brazil: By Application, 2010-2017 ($Million)
Table 142 Brazil: By Product Type, 2010-2017 ($Million)
Table 143 Russia: Aging Population (Thousand)
Table 144 Russia: IVD Market, By Technique, 2010-2017 ($Million)
Table 145 Russia: By Application, 2010-2017 ($Million)
Table 146 Russia: By Product Type, 2010-2017 ($Million)
Table 147 India: IVD Market, By Technique, 2010-2017 ($Million)
Table 148 India: By Application, 2010-2017 ($Million)
Table 149 India: By Product Type, 2010-2017 ($Million)
Table 150 China: IVD Market, By Technique, 2010-2017 ($Million)
Table 151 China: By Application, 2010-2017 ($Million)
Table 152 China: By Product Type, 2010-2017 ($Million)
Table 153 ROW: IVD Market, By Technique, 2010-2017 ($Million)
Table 154 ROW: By Application, 2010-2017 ($Million)
Table 155 ROW: By Product Type, 2010-2017 ($Million)
Table 156 New Product Launch, 2011-2013
Table 157 Agreements, Partnerships, Collaborations & Joint Ventures, 2011-2013
Table 158 Mergers & Acquisitions, 2011-2013
Table 159 Othere Developments, 2011-2013
Table 160 Abbott Laboratories, Inc.: Major Developments, 2011-2013
Table 161 Alere, Inc.: Major Developments, 2011-20113
Table 162 Arkray, Inc.: Major Developments, 2011-2013
Table 163 Bayer Ag: Major Developments, 2011-2013
Table 164 Becton, Dickinson And Company: Major Developments, 2011-2013
Table 165 Biomerieux: Major Developments, 2011-2012
Table 166 Bio-Rad Laboratories, Inc.: Major Developments, 2011-2012
Table 167 Danaher Corporation: Major Developments, 2011-2013
Table 168 Diagnostica Stago Sas: Major Developments, 2011-2013
Table 169 Diasorin Inc.: Major Developments, 2011-2013
Table 170 Hologic, Inc.: Major Developments, 2011-2013
Table 171 Horiba, Ltd.: Major Developments, 2011-2012
Table 172 Johnson & Johnson: Major Developments, 2011-2012
Table 173 Novartis Ag: Major Developments, 2011-2012
Table 174 Qaigen N.V.: Major Developments, 2011-2013
Table 175 Roche Holdings: Major Developments, 2011-2013
Table 176 Siemens Healthcare: Major Developments, 2011-2013
Table 177 Sysmex Corporation: Major Developments, 2011-2013
Table 178 Thermo Fisher Scientific, Inc.: Major Developments, 2011-2013


List Of Figures (50 Figures)

Figure 1 Global In-Vitro Diagnostic Instrument & Reagents Market,By Technique, 2012 ($Million)
Figure 2 Role Of In-Vitro Diagnostics In Healthcare
Figure 3 In Vitro Diagnostics Market Segmentation
Figure 4 In Vitro Diagnostics Market—Drivers & Restraints
Figure 5 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2012
Figure 6 In Vitrp Diagnostic Market:Supply Chain Analysis
Figure 7 In Vitro Diagnostic Market: Pestel Analysis
Figure 8 Global In Vitro Diagnostics Market Segmentation, By Technique
Figure 9 Global In Vitro Diagnostics Market, By Technique
Figure 10 Global In Vitro Diagnostics Market, By Geography, 2012
Figure 11 Key Growth Strategies, 2011-2013
Figure 12 Abbott Laboratories, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 13 Abbott Laboratories, Inc.: Market Strategy, 2011-2013
Figure 14 Alere, Inc.: Total Revenue, By Segment, 2009 - 2011 ($Million)
Figure 15 Alere, Inc.: Professional Diagnostics Revenue, By Segment, 2011-2012 ($Million)
Figure 16 Alere, Inc.: Market Strategy, 2011-2013
Figure 17 Arkray, Inc.: Market Strategy, 2011 - 2012
Figure 18 Bayer AG: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 19 Becton, Dickinson And Company: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 20 Bd Diagnostics: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 21 Becton, Dickinson And Company: Market Strategy, 2011-2013
Figure 22 Biomerieux: Total Revenue, By Segment, 2010-2011 ($Million)
Figure 23 Biomerieux: Market Strategy, 2011-2012
Figure 24 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 25 Bio-Rad Laboratories, Inc.: Market Srategy, 2011-2013
Figure 26 Danaher Corporation: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 27 Danaher Corporation: Market Strategy, 2011-2013
Figure 28 Diagnostica Stago Sas: Market Strategy, 2011-2013
Figure 29 Diasorin S.P.A.: Total Revenue, By Technology, 2010-2012, ($Million)
Figure 30 Diasorin S.P.A,: Market Strategy, 2011-2013
Figure 31 Hologic, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 32 Hologic, Inc.: Market Srategy, 2011-2013
Figure 33 Horiba Ltd.: Total Revenue, By Segments, 2009-2011
Figure 34 Horiba, Ltd.: Market Strategy, 2011 - 2013
Figure 35 Johnson & Johnson: Total Revenue, By Segment, 2010-2012 ($Milllion)
Figure 36 Johnson & Johnson: Diagnostics Franchise Revenue, 2010-2012 ($Million)
Figure 37 Johnson & Johnson: Market Strategy, 2011-2013
Figure 38 Novartis AG: Total Revenue, By Segment, 2010-2012
Figure 39 Novartis AG: Market Stretegy, 2011-2013
Figure 40 Qiagen N.V.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 41 Qiagen N.V.: Market Srategy, 2011 - 2013
Figure 42 ROCHE Holdings: Diagnostics Revenue, By Segment, 2010-2012 ($Million)
Figure 43 ROCHE Holdings: Diagnostics Revenue, By Geography, 2010-2012 ($Million)
Figure 44 ROCHE Holdings: Market Strategy, 2011-2012
Figure 45 Siemens AG: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 46 Siemens Healthcare: Market Strategy, 2011-2013
Figure 47 Sysmex Corporation: Diagnostics Segment Revenue, 2010-2012 ($Million)
Figure 48 Sysmex Corporation: Market Strategy, 2011-2013
Figure 49 Thermo Fisher Scientific, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 50 Thermo Fisher Scientific, Inc.: Market Srategy, 2011-2013

★調査レポート[世界の体外診断(IVD)市場] ( In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users]-Forecast To 2017 / PH 2087) 販売に関する免責事項
[世界の体外診断(IVD)市場] ( In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users]-Forecast To 2017 / PH 2087) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆